These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
316 related items for PubMed ID: 12149226
21. In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression. Keats JJ, Reiman T, Maxwell CA, Taylor BJ, Larratt LM, Mant MJ, Belch AR, Pilarski LM. Blood; 2003 Feb 15; 101(4):1520-9. PubMed ID: 12393535 [Abstract] [Full Text] [Related]
22. Interphase detection of t(4;14)(p16.3;q32.3) by in situ hybridization and FGFR3 overexpression in plasma cell malignancies. Nakazawa N, Nishida K, Tamura A, Kobayashi M, Iwai T, Horiike S, Nishigaki H, Otsuki T, Tomiyama Y, Fujii H, Kashima K, Taniwaki M. Cancer Genet Cytogenet; 2000 Mar 15; 117(2):89-96. PubMed ID: 10704676 [Abstract] [Full Text] [Related]
23. Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients. Fonseca R, Blood EA, Oken MM, Kyle RA, Dewald GW, Bailey RJ, Van Wier SA, Henderson KJ, Hoyer JD, Harrington D, Kay NE, Van Ness B, Greipp PR. Blood; 2002 May 15; 99(10):3735-41. PubMed ID: 11986230 [Abstract] [Full Text] [Related]
24. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells. López-Corral L, Gutiérrez NC, Vidriales MB, Mateos MV, Rasillo A, García-Sanz R, Paiva B, San Miguel JF. Clin Cancer Res; 2011 Apr 01; 17(7):1692-700. PubMed ID: 21325290 [Abstract] [Full Text] [Related]
31. Detection of chromosome 13q deletions and IgH translocations in patients with multiple myeloma by FISH: comparison with karyotype analysis. Chang H, Li D, Zhuang L, Nie E, Bouman D, Stewart AK, Chun K. Leuk Lymphoma; 2004 May 01; 45(5):965-9. PubMed ID: 15291356 [Abstract] [Full Text] [Related]
32. Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis. Harrison CJ, Mazzullo H, Ross FM, Cheung KL, Gerrard G, Harewood L, Mehta A, Lachmann HJ, Hawkins PN, Orchard KH. Br J Haematol; 2002 May 01; 117(2):427-35. PubMed ID: 11972529 [Abstract] [Full Text] [Related]
33. Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance. Zojer N, Schuster-Kolbe J, Assmann I, Ackermann J, Strasser K, Hübl W, Drach J, Ludwig H. Br J Haematol; 2002 Jun 01; 117(4):852-9. PubMed ID: 12060120 [Abstract] [Full Text] [Related]
34. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3. Chesi M, Nardini E, Brents LA, Schröck E, Ried T, Kuehl WM, Bergsagel PL. Nat Genet; 1997 Jul 01; 16(3):260-4. PubMed ID: 9207791 [Abstract] [Full Text] [Related]
35. A subset of multiple myeloma harboring the t(4;14)(p16;q32) translocation lacks FGFR3 expression but maintains an IGH/MMSET fusion transcript. Santra M, Zhan F, Tian E, Barlogie B, Shaughnessy J. Blood; 2003 Mar 15; 101(6):2374-6. PubMed ID: 12433679 [Abstract] [Full Text] [Related]